1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Weidler, M.
Marx, U.C.
Seidel, G.
Roesch, P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
FEBS Lett.
FEBLAL
0165
0014-5793
444
239
244
10.1016/S0014-5793(98)01658-5
10050767
The structure of human parathyroid hormone-related protein(1-34) in near-physiological solution.
1999
10.2210/pdb1bzg/pdb
pdb_00001bzg
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4027.636
PARATHYROID HORMONE-RELATED PROTEIN
RESIDUES 1-34
1
man
polymer
no
no
AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA
AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1999-05-18
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1998-10-28
REL
REL
ENERGY, AGREEMENT WITH EXPERIMENTAL DATA
100
30
DQF-COSY
CLEAN-TOCSY
NOESY
550mM
5.1
10E+5PA
atm
277
K
STRATEGY USED FOR NMR STRUCTURE CALCULATION: EXPERIMENTAL RESTRAINTS FOR THE STRUCTURE CALCULATIONS INITIALLY, FREQUENCY DEGENERATED NOESY CROSS-PEAKS WERE INCORPORATED INTO THE STRUCTURE CALCULATION AS 'AMBIGUOUS'. SUBSEQUENTLY, THE PROTON- PROTON DISTANCES IN THE CALCULATED STRUCTURES WERE DETERMINED USING THE PROGRAM BACKCALC_DB 2.0 (SOFTWARE SYMBIOSE, INC., BAYREUTH, GERMANY) AND COMPARED WITH THE COMBINATIONS OF DISTANCES POSSIBLE FOR EACH FREQUENCY DEGENERATED NOESY CROSS-PEAK. IF ONLY ONE OF THE POSSIBLE DISTANCE COMBINATIONS WAS FULFILLED IN MORE THAN 50% OF THE CALCULATED STRUCTURES, THE DISTANCE INFORMATION WAS USED IN FURTHER STRUCTURE CALCULATIONS. THIS PROCEDURE WAS REPEATED SEVERAL TIMES, LEADING TO A TOTAL OF 424 INTRARESIDUAL AND 337 INTERRESIDUAL NOE CONNECTIVITIES. STRUCTURES CALCULATIONS WERE PERFORMED USING A MODIFIED AB INITIO SIMULATED ANNEALING PROTOCOL (NILGES, UNPUBLISHED) WITH X-PLOR V3.840. THE CALCULATION STRATEGY INCLUDES FLOATING ASSIGNMENT OF PROCHIRAL GROUPS AND A REDUCED PRESENTATION FOR NON-BONDED INTERACTIONS FOR PART OF THE CALCULATION TO INCREASE EFFICIENCY. A MORE DETAILED DESCRIPTION OF THE PROTOCOL IS GIVEN IN KHARRAT ET AL. (EMBO J. 14 (1995) 3572-84). STRUCTURE PARAMETERS WERE EXTRACTED FROM THE STANDARD FILES PARALLHDG.PRO AND TOPALLHDG.PRO OF X-PLOR V3.840. IN EACH ROUND OF THE STRUCTURE CALCULATION 100 STRUCTURES WERE CALCULATED. OF THE 100 STRUCTURES RESULTING FROM THE FINAL ROUND OF STRUCTURE CALCULATION, THOSE 30 STRUCTURES THAT SHOWED THE LOWEST TOTAL ENERGY VALUES WERE SELECTED FOR FURTHER CHARACTERIZATION.
SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS
1
H2O/D2O (9:1)
BRUNGER
refinement
X-PLOR V3.840
V3.840
structure solution
NDEE
2.0
structure solution
X-PLOR
600
Bruker
AMX600
ALA
1
n
1
ALA
1
A
VAL
2
n
2
VAL
2
A
SER
3
n
3
SER
3
A
GLU
4
n
4
GLU
4
A
HIS
5
n
5
HIS
5
A
GLN
6
n
6
GLN
6
A
LEU
7
n
7
LEU
7
A
LEU
8
n
8
LEU
8
A
HIS
9
n
9
HIS
9
A
ASP
10
n
10
ASP
10
A
LYS
11
n
11
LYS
11
A
GLY
12
n
12
GLY
12
A
LYS
13
n
13
LYS
13
A
SER
14
n
14
SER
14
A
ILE
15
n
15
ILE
15
A
GLN
16
n
16
GLN
16
A
ASP
17
n
17
ASP
17
A
LEU
18
n
18
LEU
18
A
ARG
19
n
19
ARG
19
A
ARG
20
n
20
ARG
20
A
ARG
21
n
21
ARG
21
A
PHE
22
n
22
PHE
22
A
PHE
23
n
23
PHE
23
A
LEU
24
n
24
LEU
24
A
HIS
25
n
25
HIS
25
A
HIS
26
n
26
HIS
26
A
LEU
27
n
27
LEU
27
A
ILE
28
n
28
ILE
28
A
ALA
29
n
29
ALA
29
A
GLU
30
n
30
GLU
30
A
ILE
31
n
31
ILE
31
A
HIS
32
n
32
HIS
32
A
THR
33
n
33
THR
33
A
ALA
34
n
34
ALA
34
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
O
H
PHE
HIS
22
26
1.47
1
A
A
O
H
LYS
ILE
13
15
1.50
2
A
A
O
H
PHE
HIS
22
26
1.50
2
A
A
O
H
ASP
ARG
17
21
1.50
2
A
A
O
H
LYS
ILE
13
15
1.57
2
A
A
O
H
HIS
ALA
25
29
1.57
3
A
A
O
H
PHE
HIS
22
26
1.46
4
A
A
O
H
PHE
HIS
22
26
1.46
4
A
A
O
H
LYS
ILE
13
15
1.52
5
A
A
O
H
SER
ASP
14
17
1.32
5
A
A
O
H
PHE
HIS
22
26
1.52
5
A
A
O
H
GLY
SER
12
14
1.53
5
A
A
O
H
ILE
ARG
15
19
1.57
6
A
A
O
H
HIS
ALA
26
29
1.60
6
A
A
O
H
PHE
HIS
22
26
1.60
7
A
A
O
H
SER
ASP
14
17
1.33
7
A
A
O
H
PHE
HIS
22
26
1.45
7
A
A
O
H
GLY
SER
12
14
1.55
7
A
A
O
H
HIS
ALA
26
29
1.55
7
A
A
O
H
ILE
ARG
15
19
1.56
9
A
A
O
H
ASP
ARG
17
21
1.38
9
A
A
O
H
PHE
HIS
22
26
1.49
9
A
A
O
H
LYS
ILE
13
15
1.53
9
A
A
O
H
ARG
PHE
19
23
1.60
10
A
A
O
H
SER
ASP
14
17
1.32
10
A
A
O
H
GLY
SER
12
14
1.54
10
A
A
O
H
PHE
HIS
22
26
1.60
11
A
A
O
H
SER
ASP
14
17
1.29
11
A
A
O
H
ASP
LYS
10
13
1.48
11
A
A
O
H
GLY
SER
12
14
1.52
11
A
A
O
H
SER
GLN
3
6
1.57
11
A
A
O
H
ILE
ARG
15
19
1.58
12
A
A
O
H
PHE
HIS
22
26
1.42
12
A
A
O
H
LYS
ILE
13
15
1.50
13
A
A
O
H
SER
ASP
14
17
1.30
13
A
A
O
H
LEU
ALA
27
29
1.58
14
A
A
O
H
SER
ASP
14
17
1.32
14
A
A
O
H
PHE
HIS
22
26
1.38
14
A
A
O
H
ILE
ARG
15
19
1.50
14
A
A
O
H
GLY
SER
12
14
1.54
15
A
A
O
H
ASP
ARG
17
21
1.42
15
A
A
O
H
PHE
HIS
22
26
1.50
15
A
A
O
H
LEU
ALA
27
29
1.56
16
A
A
O
H
HIS
HIS
5
9
1.44
16
A
A
O
H
PHE
HIS
22
26
1.51
16
A
A
O
H
SER
LEU
14
18
1.54
17
A
A
O
H
ASP
ARG
17
21
1.45
17
A
A
O
H
PHE
HIS
22
26
1.51
18
A
A
O
H
ASP
ARG
17
21
1.49
18
A
A
O
H
PHE
HIS
22
26
1.50
18
A
A
O
H
SER
GLN
3
6
1.58
19
A
A
O
H
ASP
ARG
17
21
1.38
19
A
A
O
H
GLY
SER
12
14
1.48
19
A
A
O
H
PHE
HIS
22
26
1.58
20
A
A
O
H
SER
ASP
14
17
1.27
20
A
A
O
H
ASP
LYS
10
13
1.50
20
A
A
O
H
PHE
HIS
22
26
1.51
20
A
A
O
H
ILE
ARG
15
19
1.51
20
A
A
O
H
GLY
SER
12
14
1.53
20
A
A
O
H
HIS
ALA
26
29
1.56
20
A
A
O
H
HIS
HIS
5
9
1.60
21
A
A
O
H
SER
ASP
14
17
1.33
21
A
A
O
H
PHE
HIS
22
26
1.54
21
A
A
O
N
GLN
LEU
6
8
2.16
22
A
A
O
H
SER
ASP
14
17
1.21
22
A
A
O
H
ASP
ARG
17
21
1.39
22
A
A
O
H
PHE
HIS
22
26
1.45
22
A
A
O
H
ARG
PHE
19
23
1.59
23
A
A
O
H
PHE
HIS
22
26
1.44
23
A
A
O
H
ASP
ARG
17
21
1.48
24
A
A
O
H
SER
ASP
14
17
1.30
24
A
A
O
H
GLY
SER
12
14
1.54
24
A
A
O
H
HIS
HIS
5
9
1.58
24
A
A
O
H
ILE
ARG
15
19
1.58
25
A
A
O
H
ASP
ARG
17
21
1.41
25
A
A
O
H
PHE
HIS
22
26
1.44
25
A
A
O
H
LYS
ILE
13
15
1.52
25
A
A
O
H
HIS
HIS
5
9
1.54
26
A
A
O
H
PHE
HIS
22
26
1.40
26
A
A
O
H
HIS
HIS
5
9
1.52
26
A
A
O
H
ASP
ARG
17
21
1.55
27
A
A
O
H
PHE
HIS
22
26
1.47
27
A
A
O
H
LYS
ILE
13
15
1.51
27
A
A
O
H
HIS
HIS
5
9
1.56
27
A
A
O
H
SER
GLN
3
6
1.60
28
A
A
O
H
PHE
HIS
22
26
1.42
28
A
A
O
H
GLN
ARG
16
20
1.46
28
A
A
O
H
LYS
ILE
13
15
1.53
28
A
A
O
H
ASP
ARG
17
21
1.55
29
A
A
O
H
PHE
HIS
22
26
1.45
29
A
A
O
H
HIS
HIS
5
9
1.57
29
A
A
O
H
GLN
LEU
6
8
1.59
29
A
A
O
H
LYS
ILE
13
15
1.59
1
A
ARG
19
0.169
SIDE CHAIN
1
A
ARG
20
0.316
SIDE CHAIN
1
A
ARG
21
0.165
SIDE CHAIN
2
A
ARG
19
0.237
SIDE CHAIN
2
A
ARG
21
0.313
SIDE CHAIN
3
A
ARG
19
0.240
SIDE CHAIN
3
A
ARG
20
0.283
SIDE CHAIN
3
A
ARG
21
0.304
SIDE CHAIN
4
A
ARG
19
0.244
SIDE CHAIN
4
A
ARG
20
0.315
SIDE CHAIN
4
A
ARG
21
0.314
SIDE CHAIN
5
A
ARG
19
0.192
SIDE CHAIN
5
A
ARG
20
0.180
SIDE CHAIN
5
A
ARG
21
0.232
SIDE CHAIN
6
A
ARG
19
0.234
SIDE CHAIN
6
A
ARG
20
0.121
SIDE CHAIN
6
A
ARG
21
0.306
SIDE CHAIN
7
A
ARG
19
0.210
SIDE CHAIN
7
A
ARG
20
0.271
SIDE CHAIN
7
A
ARG
21
0.318
SIDE CHAIN
8
A
ARG
19
0.269
SIDE CHAIN
8
A
ARG
20
0.158
SIDE CHAIN
8
A
ARG
21
0.249
SIDE CHAIN
9
A
ARG
19
0.231
SIDE CHAIN
9
A
ARG
20
0.208
SIDE CHAIN
9
A
ARG
21
0.318
SIDE CHAIN
10
A
ARG
19
0.113
SIDE CHAIN
10
A
ARG
20
0.123
SIDE CHAIN
10
A
ARG
21
0.308
SIDE CHAIN
11
A
ARG
19
0.241
SIDE CHAIN
11
A
ARG
21
0.253
SIDE CHAIN
12
A
ARG
19
0.137
SIDE CHAIN
12
A
ARG
20
0.271
SIDE CHAIN
12
A
ARG
21
0.283
SIDE CHAIN
13
A
ARG
19
0.201
SIDE CHAIN
13
A
ARG
20
0.317
SIDE CHAIN
13
A
ARG
21
0.161
SIDE CHAIN
14
A
ARG
19
0.242
SIDE CHAIN
14
A
ARG
20
0.133
SIDE CHAIN
14
A
ARG
21
0.283
SIDE CHAIN
15
A
ARG
19
0.256
SIDE CHAIN
15
A
ARG
20
0.251
SIDE CHAIN
15
A
ARG
21
0.209
SIDE CHAIN
16
A
ARG
19
0.152
SIDE CHAIN
16
A
ARG
20
0.259
SIDE CHAIN
16
A
ARG
21
0.273
SIDE CHAIN
17
A
ARG
19
0.269
SIDE CHAIN
17
A
ARG
20
0.270
SIDE CHAIN
17
A
ARG
21
0.314
SIDE CHAIN
18
A
ARG
19
0.287
SIDE CHAIN
18
A
ARG
20
0.288
SIDE CHAIN
18
A
ARG
21
0.317
SIDE CHAIN
19
A
ARG
19
0.268
SIDE CHAIN
19
A
ARG
20
0.293
SIDE CHAIN
19
A
ARG
21
0.312
SIDE CHAIN
20
A
ARG
19
0.315
SIDE CHAIN
20
A
ARG
20
0.183
SIDE CHAIN
20
A
ARG
21
0.218
SIDE CHAIN
21
A
ARG
19
0.138
SIDE CHAIN
21
A
ARG
20
0.205
SIDE CHAIN
21
A
ARG
21
0.091
SIDE CHAIN
22
A
ARG
19
0.223
SIDE CHAIN
22
A
ARG
20
0.306
SIDE CHAIN
22
A
ARG
21
0.315
SIDE CHAIN
23
A
ARG
19
0.179
SIDE CHAIN
23
A
ARG
21
0.202
SIDE CHAIN
24
A
ARG
19
0.156
SIDE CHAIN
24
A
ARG
20
0.204
SIDE CHAIN
24
A
ARG
21
0.295
SIDE CHAIN
25
A
ARG
19
0.260
SIDE CHAIN
25
A
ARG
20
0.318
SIDE CHAIN
25
A
ARG
21
0.081
SIDE CHAIN
26
A
ARG
19
0.243
SIDE CHAIN
26
A
ARG
21
0.300
SIDE CHAIN
27
A
ARG
19
0.273
SIDE CHAIN
27
A
ARG
20
0.303
SIDE CHAIN
27
A
ARG
21
0.314
SIDE CHAIN
28
A
ARG
19
0.315
SIDE CHAIN
28
A
ARG
20
0.296
SIDE CHAIN
28
A
ARG
21
0.260
SIDE CHAIN
29
A
ARG
19
0.241
SIDE CHAIN
29
A
ARG
20
0.173
SIDE CHAIN
29
A
ARG
21
0.309
SIDE CHAIN
30
A
ARG
19
0.296
SIDE CHAIN
30
A
ARG
20
0.210
SIDE CHAIN
30
A
ARG
21
0.281
SIDE CHAIN
1
A
VAL
2
-43.58
157.05
1
A
GLN
6
-48.90
172.52
1
A
LEU
7
69.16
-69.88
1
A
HIS
9
-98.69
45.21
1
A
ASP
10
-25.77
-47.11
1
A
LYS
11
-43.92
93.41
1
A
LYS
13
-57.09
-161.87
1
A
SER
14
-69.37
58.62
1
A
PHE
23
-18.67
-75.94
1
A
ILE
28
-147.94
57.18
1
A
ALA
29
162.35
93.75
1
A
GLU
30
172.61
106.24
1
A
HIS
32
-59.55
89.19
2
A
VAL
2
-42.15
150.96
2
A
GLN
6
-45.43
159.45
2
A
LEU
7
75.30
-50.02
2
A
ASP
10
-37.25
93.17
2
A
LYS
13
-55.21
-166.50
2
A
ILE
15
-147.44
-51.05
2
A
PHE
23
-22.62
-73.97
2
A
ALA
29
175.08
150.84
2
A
HIS
32
-38.49
107.17
3
A
GLN
6
-45.32
162.37
3
A
LEU
7
76.83
-49.39
3
A
LYS
13
-77.14
-156.81
3
A
PHE
23
-21.76
-66.43
3
A
ALA
29
162.60
145.36
4
A
VAL
2
-42.36
154.28
4
A
GLN
6
-86.20
32.87
4
A
HIS
9
-44.05
-74.41
4
A
LYS
11
38.35
28.54
4
A
LYS
13
-101.61
-152.94
4
A
PHE
23
-21.45
-79.59
4
A
ALA
29
-151.54
41.20
4
A
GLU
30
159.94
82.76
5
A
GLN
6
-48.66
172.10
5
A
LEU
7
70.95
-66.96
5
A
ASP
10
21.50
-94.53
5
A
LYS
11
22.90
87.55
5
A
LYS
13
-66.44
62.46
5
A
SER
14
44.28
96.20
5
A
ILE
15
-25.36
-39.41
5
A
PHE
23
-23.47
-77.32
5
A
ILE
28
-100.73
50.76
5
A
ALA
29
165.48
86.92
5
A
GLU
30
-164.66
50.86
5
A
HIS
32
161.98
62.90
6
A
VAL
2
49.60
19.44
6
A
LEU
7
-94.21
-66.73
6
A
HIS
9
-88.20
38.42
6
A
ASP
10
-40.06
88.98
6
A
LYS
11
-53.70
100.46
6
A
LYS
13
-67.88
-155.20
6
A
PHE
23
-20.95
-60.04
6
A
ALA
29
179.58
149.47
7
A
GLU
4
-54.14
-97.28
7
A
GLN
6
-43.62
163.46
7
A
LEU
7
73.11
-52.05
7
A
ASP
10
-33.26
104.20
7
A
LYS
13
-68.18
62.01
7
A
SER
14
45.22
99.01
7
A
ILE
15
-37.37
-29.62
7
A
PHE
23
-22.71
-78.74
7
A
ALA
29
164.65
133.49
7
A
GLU
30
-69.93
56.48
7
A
HIS
32
-53.46
87.04
7
A
THR
33
43.60
74.76
8
A
VAL
2
-42.42
162.05
8
A
GLN
6
-47.67
171.80
8
A
LEU
7
69.48
-70.22
8
A
HIS
9
-98.22
41.37
8
A
ASP
10
-30.02
147.61
8
A
LYS
11
-86.05
30.93
8
A
SER
14
31.40
40.27
8
A
PHE
23
-24.11
-69.05
8
A
ALA
29
165.42
120.57
8
A
HIS
32
45.99
84.16
8
A
THR
33
53.65
101.36
9
A
GLU
4
-71.24
-71.06
9
A
GLN
6
-44.92
160.53
9
A
LEU
7
74.47
-51.66
9
A
ASP
10
-39.62
-28.98
9
A
LYS
11
-42.69
91.37
9
A
LYS
13
-56.35
-164.38
9
A
SER
14
-69.80
62.42
9
A
PHE
23
-11.27
-75.90
9
A
HIS
26
-86.37
-73.78
9
A
ILE
28
-97.60
46.10
9
A
ALA
29
162.35
117.41
9
A
ILE
31
31.40
84.94
9
A
THR
33
44.68
96.03
10
A
VAL
2
-42.18
152.53
10
A
GLN
6
-45.51
159.09
10
A
LEU
7
75.35
-51.84
10
A
ASP
10
28.02
-88.27
10
A
LYS
11
1.37
83.95
10
A
LYS
13
-68.41
62.04
10
A
SER
14
46.05
98.28
10
A
ILE
15
-36.56
-30.20
10
A
PHE
23
-24.98
-75.81
10
A
ILE
28
-155.36
-37.25
10
A
ALA
29
170.90
138.70
10
A
THR
33
60.37
164.66
11
A
SER
3
39.50
98.82
11
A
GLN
6
-44.94
161.14
11
A
LEU
7
74.16
-52.35
11
A
ASP
10
28.67
-87.40
11
A
LYS
11
-40.96
95.58
11
A
LYS
13
-67.57
63.04
11
A
SER
14
38.46
97.45
11
A
ILE
15
-29.96
-37.32
11
A
PHE
23
-24.45
-82.37
11
A
HIS
26
-74.95
-74.51
11
A
ILE
28
-76.43
-93.61
11
A
ALA
29
-45.66
164.22
11
A
GLU
30
44.01
-173.54
11
A
HIS
32
50.76
83.88
11
A
THR
33
71.72
151.47
12
A
GLN
6
-47.19
160.64
12
A
LEU
7
75.64
-50.97
12
A
ASP
10
25.55
89.61
12
A
LYS
11
-43.61
99.89
12
A
LYS
13
-56.62
-162.08
12
A
SER
14
-68.10
58.86
12
A
PHE
23
-20.91
-73.88
12
A
ALA
29
165.76
124.83
12
A
HIS
32
-43.67
150.90
13
A
VAL
2
42.08
-168.05
13
A
GLN
6
-50.07
174.86
13
A
LEU
7
68.55
-67.01
13
A
HIS
9
-93.76
38.07
13
A
ASP
10
-33.33
92.37
13
A
LYS
13
-65.71
70.59
13
A
SER
14
28.23
99.73
13
A
ILE
15
-35.27
-33.46
13
A
PHE
23
-23.11
-78.61
13
A
LEU
27
-51.00
-178.92
13
A
ILE
28
66.80
-59.85
13
A
ALA
29
-163.52
90.83
14
A
LEU
7
-102.00
-66.70
14
A
HIS
9
-93.96
44.21
14
A
ASP
10
-39.07
92.34
14
A
LYS
13
-68.43
62.05
14
A
SER
14
42.46
95.09
14
A
ILE
15
-36.07
-31.74
14
A
PHE
23
-23.88
-54.61
14
A
ALA
29
170.58
159.54
14
A
GLU
30
-171.84
136.52
14
A
HIS
32
-107.58
51.17
15
A
SER
3
38.53
97.04
15
A
GLN
6
-49.07
172.85
15
A
LEU
7
71.93
-66.71
15
A
ASP
10
28.07
79.85
15
A
LYS
13
52.14
133.93
15
A
SER
14
39.08
35.86
15
A
PHE
23
-22.16
-76.12
15
A
LEU
27
-63.38
-166.92
15
A
ILE
28
66.04
-57.64
15
A
GLU
30
59.19
114.16
15
A
HIS
32
165.40
71.85
15
A
THR
33
-150.97
54.78
16
A
SER
3
-56.57
177.66
16
A
GLN
6
-46.94
168.50
16
A
LEU
7
68.01
-69.16
16
A
LYS
13
-23.56
151.90
16
A
PHE
23
-17.48
-76.25
16
A
HIS
26
-85.35
-74.03
16
A
ILE
28
-68.03
-90.68
16
A
ALA
29
-54.87
170.16
16
A
ILE
31
-107.48
43.54
16
A
HIS
32
-55.38
82.06
17
A
VAL
2
-43.97
161.77
17
A
GLN
6
-42.62
158.41
17
A
LEU
7
76.01
-49.58
17
A
ASP
10
-39.33
92.53
17
A
LYS
13
52.41
131.80
17
A
PHE
23
-27.27
-82.23
17
A
LEU
27
-36.36
-30.75
17
A
ILE
28
-107.37
-88.39
17
A
GLU
30
-173.76
140.37
17
A
ILE
31
56.12
111.01
18
A
SER
3
40.51
101.50
18
A
GLN
6
-47.25
170.24
18
A
LEU
7
69.81
-67.47
18
A
HIS
9
-48.58
-76.03
18
A
LYS
11
44.08
23.08
18
A
LYS
13
53.28
133.38
18
A
PHE
23
-13.58
-78.34
18
A
ALA
29
162.36
114.38
18
A
HIS
32
-44.93
95.70
18
A
THR
33
-69.00
87.69
19
A
VAL
2
-49.79
152.57
19
A
GLN
6
-46.30
163.12
19
A
LEU
7
73.08
-52.56
19
A
LYS
11
-73.73
42.62
19
A
LYS
13
-60.62
48.27
19
A
ILE
15
164.77
-64.89
19
A
PHE
23
-18.55
-77.33
19
A
ALA
29
162.54
-178.48
19
A
GLU
30
178.75
143.56
19
A
THR
33
53.97
102.57
20
A
GLN
6
-45.65
167.54
20
A
LEU
7
70.81
-63.32
20
A
ASP
10
26.87
-89.04
20
A
LYS
11
-40.69
89.83
20
A
SER
14
53.26
92.64
20
A
ILE
15
-34.29
-32.16
20
A
GLN
16
-31.06
-38.44
20
A
PHE
23
-22.35
-78.21
20
A
ALA
29
49.71
95.71
21
A
GLU
4
-57.61
-71.47
21
A
HIS
5
-42.24
-95.61
21
A
GLN
6
42.22
-160.08
21
A
LEU
7
39.49
-79.50
21
A
ASP
10
20.48
55.14
21
A
LYS
13
37.18
69.72
21
A
SER
14
57.36
97.89
21
A
ILE
15
-37.37
-28.82
21
A
GLN
16
-32.55
-39.24
21
A
PHE
23
-22.65
-75.74
21
A
ALA
29
159.69
84.55
22
A
GLN
6
-49.56
175.21
22
A
LEU
7
68.48
-68.71
22
A
HIS
9
-97.13
39.30
22
A
ASP
10
-28.69
93.06
22
A
LYS
11
-50.07
88.86
22
A
LYS
13
32.37
38.67
22
A
SER
14
49.57
90.89
22
A
ILE
15
-34.47
-27.92
22
A
GLN
16
-37.79
-31.58
22
A
PHE
23
-11.19
-74.85
22
A
ALA
29
175.37
159.54
22
A
GLU
30
54.89
101.34
22
A
HIS
32
38.60
50.99
23
A
GLN
6
-45.72
161.09
23
A
LEU
7
75.88
-50.80
23
A
ASP
10
29.18
87.33
23
A
LYS
11
-43.53
102.70
23
A
LYS
13
-67.99
-159.77
23
A
PHE
23
-21.55
-70.56
23
A
ALA
29
172.41
116.68
23
A
GLU
30
-167.95
78.05
24
A
GLU
4
-83.98
-71.01
24
A
GLN
6
-46.82
167.35
24
A
LEU
7
67.87
-69.52
24
A
HIS
9
-45.11
-78.59
24
A
LYS
11
-47.63
88.42
24
A
LYS
13
-69.16
64.46
24
A
SER
14
41.16
100.26
24
A
ILE
15
-33.95
-34.88
24
A
PHE
23
-24.90
-82.62
24
A
LEU
27
-24.53
-88.57
24
A
ILE
28
-53.90
-84.21
24
A
ALA
29
-63.82
91.14
24
A
HIS
32
168.34
57.02
25
A
VAL
2
-42.88
156.42
25
A
GLN
6
-45.65
164.79
25
A
LEU
7
67.71
-68.18
25
A
HIS
9
-41.45
-82.64
25
A
ASP
10
-81.09
-110.98
25
A
LYS
11
35.52
31.28
25
A
LYS
13
-57.48
-157.19
25
A
SER
14
-67.87
62.68
25
A
PHE
23
-23.54
-83.55
25
A
ILE
28
40.55
23.36
25
A
ALA
29
62.80
160.23
25
A
HIS
32
-46.18
109.63
25
A
THR
33
76.16
124.74
26
A
VAL
2
-43.77
157.88
26
A
GLU
4
-86.44
-74.00
26
A
GLN
6
-47.23
169.78
26
A
LEU
7
72.95
-63.84
26
A
ASP
10
15.81
108.28
26
A
LYS
13
-55.21
-164.38
26
A
PHE
23
-15.09
-74.14
26
A
ILE
28
-72.34
-87.64
26
A
GLU
30
40.16
75.27
26
A
HIS
32
174.87
144.05
27
A
VAL
2
-43.17
159.76
27
A
SER
3
37.88
93.88
27
A
GLN
6
-49.77
175.38
27
A
LEU
7
70.19
-70.05
27
A
HIS
9
-91.03
37.37
27
A
ASP
10
-34.43
94.05
27
A
LYS
11
-66.70
99.97
27
A
LYS
13
-58.23
-155.41
27
A
SER
14
-68.93
61.87
27
A
PHE
23
-20.10
-71.13
27
A
ILE
28
-85.41
-74.58
27
A
GLU
30
-177.99
70.59
27
A
HIS
32
-53.22
87.05
27
A
THR
33
-101.62
51.43
28
A
GLN
6
-47.32
170.40
28
A
LEU
7
69.32
-68.62
28
A
HIS
9
-90.61
35.49
28
A
ASP
10
-25.81
124.46
28
A
LYS
13
-55.40
-164.09
28
A
SER
14
-69.34
60.95
28
A
ARG
19
-90.94
-63.01
28
A
PHE
23
-27.07
-70.53
28
A
HIS
26
-54.47
-72.78
28
A
ALA
29
77.91
71.22
28
A
HIS
32
-56.10
105.66
28
A
THR
33
46.75
-171.66
29
A
VAL
2
52.03
18.70
29
A
GLN
6
-47.56
172.65
29
A
LEU
7
69.33
-62.84
29
A
ASP
10
24.12
-88.77
29
A
LYS
11
36.22
30.35
29
A
LYS
13
-59.52
-165.45
29
A
PHE
23
-19.43
-75.72
29
A
ALA
29
162.08
-179.10
29
A
GLU
30
50.11
73.00
29
A
ILE
31
-144.57
44.19
29
A
HIS
32
-38.17
105.37
29
A
THR
33
-108.01
67.23
30
A
VAL
2
-43.26
158.51
30
A
GLU
4
-100.15
-62.50
30
A
LEU
7
-98.50
-68.46
30
A
ASP
10
28.79
-99.94
30
A
LYS
11
33.54
32.26
30
A
LYS
13
-55.11
-163.42
30
A
PHE
23
-20.61
-69.97
30
A
ALA
29
172.08
82.55
model building
X-PLOR
3.0
refinement
X-PLOR
3.0
phasing
X-PLOR
3.0
THE SOLUTION STRUCTURE OF HUMAN PARATHYROID HORMONE-RELATED PROTEIN (1-34) IN NEAR-PHYSIOLOGICAL SOLUTION, NMR, 30 STRUCTURES
1
Y
N
A
HIS
5
A
HIS
5
HELX_P
A
LEU
8
A
LEU
8
1
1
4
A
GLN
16
A
GLN
16
HELX_P
A
LEU
27
A
LEU
27
1
2
12
HORMONE
HUMAN PEPTIDE HORMONE, STIMULATING INTRACELLULAR CAMP FORMATION, SERUM CALCIUM LEVEL, HUMORAL HYPERCALCEMIA OF MALIGNANCY, SOLUTION STRUCTURE, PTHRP, PTH, HORMONE
PTHR_HUMAN
UNP
1
1
P12272
MQRRLVQQWSVAVFLLSYAVPSCGRSVEGLSRRLKRAVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATSEVSP
NSKPSPNTKNHPVRFGSDDEGRYLTQETNKVETYKEQPLKTPGKKKKGKPGKRKEQEKKKRRTRSAWLDSGVTGSGLEGD
HLSDTSTTSLELDSRRH
37
70
1BZG
1
34
P12272
A
1
1
34
1
P 1